Evidence map›Paper›PMID 31802151›Full record

ArticleEuropean biophysics journal : EBJ2020

Binding of HasA by its transmembrane receptor HasR follows a conformational funnel mechanism.

Thomas E Exner, Stefanie Becker, Simon Becker, Audrey Boniface-Guiraud, Philippe Delepelaire, Kay Diederichs, Wolfram Welte

Open access · hybridAbstract read
In one paragraph

Article in European biophysics journal : EBJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Thomas E ExnerPharmazeutisches Institut, University of Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.
Stefanie BeckerDepartment of Biology, University of Konstanz, Universitätsstr. 10, 78457, Constance, Germany.
Simon BeckerDepartment of Biology, University of Konstanz, Universitätsstr. 10, 78457, Constance, Germany.
Audrey Boniface-GuiraudUnité Des Membranes Bactériennes, Centre National de La Recherche Scientifique, Unité de Recherche, Associée 2172, Inst. Pasteur, 75005, Paris, France.
Philippe DelepelaireInstitut de Biologie Physico-Chimique, UMR 7099, CNRS Université Paris Diderot 13, rue Pierre et Marie Curie, 75005, Paris, France.
Kay DiederichsDepartment of Biology, University of Konstanz, Universitätsstr. 10, 78457, Constance, Germany.
Wolfram WelteDepartment of Biology, University of Konstanz, Universitätsstr. 10, 78457, Constance, Germany. wolfram.welte@uni-konstanz.de.ORCID http://orcid.org/0000-0002-1785-9730
University of Konstanz · DECentre National de la Recherche Scientifique · FRUniversity of Tübingen · DE

Funding

Agence Nationale de la Recherche ANR-08-BLAN-0160Agence Nationale de la Recherche ANR-12-BSV3-0022-01Deutsche Forschungsgemeinschaft WE 962/11-1
6 · The paper itself

Abstract

HasR in the outer membrane of Serratia marcescens binds secreted, heme-loaded HasA and translocates the heme to the periplasm to satisfy the cell's demand for iron. The previously published crystal structure of the wild-type complex showed HasA in a very specific binding arrangement with HasR, apt to relax the grasp on the heme and assure its directed transfer to the HasR-binding site. Here, we present a new crystal structure of the heme-loaded HasA arranged with a mutant of HasR, called double mutant (DM) in the following that seemed to mimic a precursor stage of the abovementioned final arrangement before heme transfer. To test this, we performed first molecular dynamics (MD) simulations starting at the crystal structure of the complex of HasA with the DM mutant and then targeted MD simulations of the entire binding process beginning with heme-loaded HasA in solution. When the simulation starts with the former complex, the two proteins in most simulations do not dissociate. When the mutations are reverted to the wild-type sequence, dissociation and development toward the wild-type complex occur in most simulations. This indicates that the mutations create or enhance a local energy minimum. In the targeted MD simulations, the first protein contacts depend upon the chosen starting position of HasA in solution. Subsequently, heme-loaded HasA slides on the external surface of HasR on paths that converge toward the specific arrangement apt for heme transfer. The targeted simulations end when HasR starts to relax the grasp on the heme, the subsequent events being in a time regime inaccessible to the available computing power. Interestingly, none of the ten independent simulation paths visits exactly the arrangement of HasA with HasR seen in the crystal structure of the mutant. Two factors which do not exclude each other could explain these observations: the double mutation creates a non-physiologic potential energy minimum between the two proteins and /or the target potential in the simulation pushes the system along paths deviating from the low-energy paths of the native binding processes. Our results support the former view, but do not exclude the latter possibility.

Indexed as

Molecular Dynamics SimulationBacterial ProteinsBinding SitesCarrier ProteinsHemeMembrane ProteinsMutationProtein BindingReceptors, Cell SurfaceSerratia marcescensBacterial ProteinsCarrier ProteinsHasA protein, Serratia marcescensHemeMembrane ProteinsReceptors, Cell SurfaceCrystal structureHasAHasRHeme acquisition systemOuter membraneSerratia marcescens

Identifiers

PMID31802151
PMCPMC6981324
OpenAlexW2994098350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.